APOE and Alzheimer disease: This result is in line with previous literature that has shown that APOE-ε4 carriership may accelerate AD-related brain atrophy (Evans et al., 2014; Filippini et al., 2011), as accelerated brain aging has also been found in MCI and AD patients (Beheshti et al., 2018; Kaufmann et al., 2019).